Dunfang Zhang

14PUBLICATIONS
43CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMultiphysics flows (incl. multiphase and reacting flows)Carbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 29, 2026
SRSF3 determines Treg cell fate in antitumor immunity and autoimmunity.

|Jan 15, 2026
[Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions].

Wei Zhang, Zhenhong Li, Hantian Liang

|Nov 29, 2025
Epithelial pyroptosis-induced TREM1+ macrophages activate Th17 cells to accelerate oral mucosal inflammation.

Qianhui Shang, Ziyuan Wang, Jiakuan Peng

|Sep 18, 2025
[Oxidative Stress Induced by High Glucose Aggravates Immunosuppression in Diabetes Mellitus by Promoting Effector T Cell Apoptosis and Regulatory T Cell Differentiation].

Xiao Ma, Zhenhong Li, Wenjing Chen

|Aug 25, 2025
High fructose consumption aggravates inflammation by promoting effector T cell generation via inducing metabolic reprogramming.

Xiao Ma, Jiao Chen, Fang Wang

|Aug 16, 2025
Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2.

Hao Cheng, Fang Nan, Ning Ji

Pageof 3

Frequent Collaborators

6 joint publications

WanJun Chen

3 joint publications

Hiroko Nakatsukasa

2 joint publications

Hao Xu

2 joint publications

Xikun Zhou